Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014

Date: March 31, 2014
Pages: 209
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: MF6567C4B73EN
Leaflet:

Download PDF Leaflet

Summary

GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014' provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Breast Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Metastatic Breast Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Metastatic Breast Cancer to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Metastatic Breast Cancer to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Metastatic Breast Cancer
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Metastatic Breast Cancer Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Metastatic Breast Cancer
Feb 27, 2014: Eisai Announces Initiation of a Phase 3 Trial of Eribulin Mesylate Injection Versus Weekly Paclitaxel in First and Second Lines of Metastatic Breast Cancer
Jan 14, 2014: Etirinotecan Pegol Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer
Oct 21, 2013: Seattle Genetics Initiates Phase 1 Trial of ADC Candidate, SGN-LIV1A, for Patients with LIV-1-Positive Metastatic Breast Cancer
Sep 03, 2013: Oncothyreon Announces Initiation of Phase 1 Trial of ONT-380 in Combination with Trastuzumab in Patients with Brain Metastases from HER2+ Breast Cancer
Jul 30, 2013: Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Novartis AG
Clinical Trial Overview of Novartis AG
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Sanofi
Clinical Trial Overview of Sanofi
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Sarah Cannon Research Institute
Clinical Trial Overview of Sarah Cannon Research Institute
North Central Cancer Treatment Group
Clinical Trial Overview of North Central Cancer Treatment Group
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
FUDAN University
Clinical Trial Overview of FUDAN University
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Metastatic Breast Cancer Therapeutics, Global, Clinical Trials by Region, 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014
Proportion of Metastatic Breast Cancer to Oncology Clinical Trials, G7 Countries (%), 2014
Metastatic Breast Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Metastatic Breast Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Metastatic Breast Cancer to Oncology Clinical Trials, E7 Countries (%), 2014
Metastatic Breast Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Metastatic Breast Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials by Phase, 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014
Metastatic Breast Cancer Therapeutics, Global, Suspended Clinical Trials, 2014
Metastatic Breast Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014
Metastatic Breast Cancer Therapeutics, Global, Terminated Clinical Trials, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2014

LIST OF FIGURES

Metastatic Breast Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014
Proportion of Metastatic Breast Cancer to Oncology Clinical Trials, G7 Countries (%), 2014
Metastatic Breast Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Metastatic Breast Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Metastatic Breast Cancer to Oncology Clinical Trials, E7 Countries (%), 2014
Metastatic Breast Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Metastatic Breast Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Metastatic Breast Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Ask Your Question

Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: